MC
GSK icon

Mathes Company’s GSK GSK Stock Holding History

Mathes Company’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-6,720
Closed -$341K – 145
2017
Q3 		$341K Hold
6,720
– – 0.16% 112
2017
Q2 		$362K Hold
6,720
– – 0.17% 106
2017
Q1 		$354K Hold
6,720
– – 0.19% 99
2016
Q4 		$323K Buy
6,720
+800
+14% +$39.5K 0.18% 105
2016
Q3 		$319K Hold
5,920
– – 0.18% 103
2016
Q2 		$321K Buy
5,920
+960
+19% +$50.6K 0.19% 104
2016
Q1 		$251K Buy
+4,960
New +$247K 0.15% 110

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Mathes Company's GSK Position: Q4 2017 in Review

Mathes Company sold out of GSK (GSK) in Q4 2017, closing a stake of 6,720 shares — an estimated $341K sold.

Mathes Company first reported a position in GSK in Q1 2016 and held it in 7 quarters. The position peaked at $362K in Q2 2017. 763 funds tracked by Wall St. Rank hold GSK as of Q4 2017.

  • Mathes Company reported no remaining GSK position as of Q4 2017 after selling out during the quarter.
  • Mathes Company sold 6,720 GSK shares in Q4 2017, an estimated $341K.
  • Mathes Company first reported a position in GSK in Q1 2016 and held it in 7 quarters.
  • Mathes Company's GSK position peaked at $362K in Q2 2017.
  • 763 funds tracked by Wall St. Rank held GSK as of Q4 2017.

Based on Mathes Company's 13F filing for Q4 2017, filed 19 Jan 2018.